Loading page…

Report overview

The report presents Eurofarma's first Integrated Reporting-format publication, covering consolidated results across its operations. It reports BRL 12.48 billion in net revenue, 97% renewable electricity across global operations, and a Scope 3 total of 992,413 tCO2e after mapping all applicable categories. KPMG provided limited assurance over the GRI indicators, while the GHG inventory was independently verified with reasonable assurance.

Document

Report type: Integrated Report
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 30 April 2026
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level
CDP score

Assurance

Provider
Level
Scope
Statement included
Metrics assured

ESG & Materiality

ESG data

Indicators available in this report:

Scope 1 emissions
Scope 2 emissions
Scope 3 emissions
Energy consumption
Renewable energy
Water consumption
Waste
Employees
Women on the board

Materiality

Assessment
Basis

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services